Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-14 3:32 pm Purchase | 2024-09-30 | 13G | Pasithea Therapeutics Corp. KTTA | ARMISTICE CAPITAL LLC | 115,880 9.990% | 115,880 (New Position) | Filing History |
| 2023-06-07 6:29 pm Purchase | 2023-06-02 | 13D | Pasithea Therapeutics Corp. KTTA | STEINMAN LAWRENCE | 78,859 6.000% | 78,859 (New Position) | Filing History |
| 2023-02-14 6:28 pm Unchanged | 2022-10-22 | 13G | Pasithea Therapeutics Corp. KTTA | Manning Paul B | 170,435 11.300% | 0 (Unchanged) | Filing History |
| 2023-01-13 08:02 am Sale | 2022-12-31 | 13G | Pasithea Therapeutics Corp. KTTA | Khire Uday | 61,405 4.600% | -12,228 (-16.61%) | Filing History |
| 2023-01-10 3:55 pm Sale | 2023-01-10 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 0 0.000% | -89,421 (Position Closed) | Filing History |
| 2022-12-13 7:26 pm Unchanged | 2022-12-09 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 89,421 6.100% | 0 (Unchanged) | Filing History |
| 2022-11-01 5:28 pm Purchase | 2022-10-31 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 89,421 6.700% | 4,305 (+5.06%) | Filing History |
| 2022-10-20 11:11 am Purchase | 2022-10-11 | 13G | Pasithea Therapeutics Corp. KTTA | Khire Uday | 73,633 5.000% | 73,633 (New Position) | Filing History |
| 2022-09-06 4:10 pm Purchase | 2022-09-02 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 85,116 6.400% | 3,358 (+4.11%) | Filing History |
| 2022-09-01 06:05 am Purchase | 2022-08-19 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 81,758 6.100% | 8,980 (+12.34%) | Filing History |
| 2022-08-11 10:26 am Purchase | 2022-08-09 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 72,778 5.500% | 14,441 (+24.75%) | Filing History |
| 2022-07-27 9:45 pm Purchase | 2022-07-27 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 58,337 4.400% | 6,602 (+12.76%) | Filing History |
| 2022-06-29 4:30 pm Purchase | 2022-06-22 | 13G | Pasithea Therapeutics Corp. KTTA | Manning Paul B | 170,435 9.800% | 170,435 (New Position) | Filing History |
| 2022-06-24 6:16 pm Unchanged | 2022-06-23 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 51,735 4.400% | 0 (Unchanged) | Filing History |
| 2022-06-16 10:29 am Unchanged | 2022-06-14 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 51,735 4.400% | 0 (Unchanged) | Filing History |
| 2022-06-01 10:08 am Purchase | 2022-05-22 | 13D | Pasithea Therapeutics Corp. KTTA | Camac Fund LP | 51,735 4.400% | 51,735 (New Position) | Filing History |
| 2022-02-03 3:53 pm Purchase | 2021-12-31 | 13G | Pasithea Therapeutics Corp. KTTA | Ionic Ventures, LLC | 43,513 2.850% | 5,680 (+15.01%) | Filing History |
| 2022-01-31 6:21 pm Sale | 2021-12-31 | 13G | Pasithea Therapeutics Corp. KTTA | K2 PRINCIPAL FUND L.P. | 54,721 4.990% | -30,279 (-35.62%) | Filing History |
| 2022-01-13 10:56 am Sale | 2021-12-31 | 13G | Pasithea Therapeutics Corp. KTTA | ALPHA CAPITAL ANSTALT | 35,750 3.267% | -5,838 (-14.04%) | Filing History |
| 2021-12-20 4:00 pm Purchase | 2021-11-29 | 13G | Pasithea Therapeutics Corp. KTTA | K2 PRINCIPAL FUND L.P. | 85,000 7.480% | 85,000 (New Position) | Filing History |